TABLE 2.
Characteristics of participants enrolled, 2014 to 2018a
| Characteristic | Value for participants in the following group: |
|||
|---|---|---|---|---|
| Type 1 (n = 196) | Type 2 (n = 102) | EC (n = 252) | Total (n = 550) | |
| No. of participants by yr [site(s)] | ||||
| 2014 (EH) | 10 | 12 | 22 | 44 |
| 2015 (EH, MV) | 27 | 16 | 33 | 76 |
| 2016 (EH, MV, WI) | 47 | 29 | 71 | 147 |
| 2017 (EH, WI) | 65 | 25 | 78 | 168 |
| 2018 (EH, WI) | 47 | 20 | 48 | 115 |
| No. of participants by site (type) | ||||
| EH total (type 1A, type 1B) | 123 (101, 22) | 59 | 136 | 318 |
| MV total (type 1A, type 1B) | 11 (8, 3) | 11 | 18 | 40 |
| WI total (type 1A, type 1B) | 62 (39, 23) | 32 | 98 | 192 |
| No. (%) of participants with the following signs and symptoms: | ||||
| Headache | 70 (36) | 81 (79) | NA | |
| Fatigue | 96 (49) | 80 (78) | NA | |
| Fever | 36 (18) | 45 (44) | NA | |
| Chills | 55 (28) | 45 (44) | NA | |
| Joint/muscle pain | 88 (45) | 78 (76) | NA | |
a
Abbreviations and definitions: EH, East Hampton, NY; MV, Martha’s Vineyard, MA; WI, Marshfield, WI; type 1A, EM lesion size of >5 cm; type 1B, EM/annular lesion size of ≤5 cm; NA, not applicable.